Issues in clinical trial design from the FDA perspective

Russell Katz¹

• ¹Division of Neuropharmacological Drug Products, Center for Drug Evaluation and Research, Office of Drug Evaluation I, Food and Drug Administration, Rockville, Maryland 20852, USA. katzr@cder.fda.gov